Kidney Sales and Market Regulation: A Reply to Semrau.

Clicks: 260
ID: 51257
2017
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Luke Semrau argues that the documented harms of existing organ markets do not undermine the case for establishing regulated systems of paid kidney donation. He offers two arguments in support of this conclusion. First, Semrau argues that the harms of kidney selling are straightforwardly amenable to regulatory solution. Second, Semrau argues that even in existing black markets, sellers would likely have experienced greater harm if the option of selling a kidney were not available. This commentary challenges both of Semrau's claims. I argue that there is no reason to believe that kidney sellers benefit from the current black market trade in organs, and highlight a number of potential issues regarding the effectiveness and feasibility of Semrau's proposed market regulations.
Reference Key
koplin2017kidneythe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Koplin, Julian J;
Journal the journal of medicine and philosophy
Year 2017
DOI
10.1093/jmp/jhx023
URL
Keywords
regulation burden of proof harm kidney markets organ transplantation

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.